Considerations for instituting pediatric pulmonary embolism response teams: A tool kit.

Critical pathways Pediatrics Pulmonary embolism

Journal

Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 21 12 2023
revised: 14 02 2024
accepted: 16 02 2024
medline: 29 2 2024
pubmed: 29 2 2024
entrez: 28 2 2024
Statut: aheadofprint

Résumé

The incidence of pediatric pulmonary embolism (PE) has increased by 200 % in the last decade, but at a single center, it is still infrequent. Given the unique epidemiologic features of pediatric PE, diagnosis is often delayed, and the management is empiric, based on individual physician experience or preference. Thus, there is a strong need for center-specific uniform management of pediatric PE patients. In adults, the development of pulmonary embolism response teams (PERTs) or PE critical care pathways has shortened the time to diagnosis and the initiation of definitive management. Evidence to support an improvement in PE outcomes after the development of PERTs does not exist in children. Nonetheless, we have summarized the practical practice guidelines that physicians and institutions can adopt to establish their institutional PERTs or critical pathways. We also provide strategies for resource-challenged institutions for partnering with centers with expertise in the management of pediatric PE.

Identifiants

pubmed: 38417301
pii: S0049-3848(24)00054-9
doi: 10.1016/j.thromres.2024.02.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-107

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest relevant to this article to disclose.

Auteurs

Madhvi Rajpurkar (M)

Department of Pediatrics, Division of Pediatric Hematology Oncology, Central Michigan University, Wayne State University, Children's Hospital of Michigan, Detroit, MI, USA. Electronic address: rajpu1ma@cmich.edu.

Rachel P Rosovsky (RP)

Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Suzan Williams (S)

Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Canada.

Anthony K C Chan (AKC)

McMaster Children's Hospital, McMaster University, Canada.

C Heleen van Ommen (CH)

Department of Pediatric Hematology, Erasmus MC Sophia Children's Hospital, Rotterdam, the Netherlands.

E Vincent S Faustino (EVS)

Section of Pediatric Critical Care Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA.

Melissa White (M)

Division of Emergency Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Mihir Parikh (M)

Department of Pediatric Anesthesiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Nongnuch Sirachainan (N)

Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand.

Tina Biss (T)

Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Neil A Goldenberg (NA)

Department of Pediatrics and Medicine, Division of Hematology, Johns Hopkins, University School of Medicine, Baltimore, MD, USA; Johns Hopkins All Children's Institute for Clinical and Translational Research, Cancer and Blood Disorder Institute, and Heart Institute, Johns Hopkins All Children's, Hospital, St. Petersburg, FL, USA.

Classifications MeSH